From Model Establishment to Functional Assessment and Molecular Mechanism

An integrated research solution designed to support comprehensive blood–brain barrier (BBB) investigation—from establishing physiologically relevant BBB models and assessing barrier function to characterizing molecular changes, neurovascular interactions, and disease-associated mechanisms.

Build the Barrier → Measure Function → Validate Molecular Features → Characterize the NVU → Decode BBB Dysfunction

Structure and cellular components of the human blood-brain barrier (BBB)

 (PMID: 41126959)

Integrated blood–brain barrier research solution

One Integrated Workflow for Comprehensive BBB Research

The BBB is a dynamic neurovascular interface that selectively regulates molecular transport between the circulation and the central nervous system.

Our integrated solution connects BBB model systems, functional assays, antibody-based molecular validation, neurovascular unit characterization, and disease-mechanism profiling to support research from basic barrier biology to therapeutic evaluation.

n  BBB physiology

Characterize endothelial identity, tight junction organization and barrier integrity.

n  Neuroinflammation

Investigate inflammatory signaling and inflammation-associated barrier disruption.

n  Neurodegeneration

Study Aβ/Tau-associated vascular dysfunction and neurovascular alterations.

n  Stroke and ischemia

Evaluate ischemia-associated endothelial injury and BBB breakdown.

n  Brain tumor

Characterize tumor-associated vascular remodeling and BBB dysfunction.

n  Drug delivery

Investigate BBB permeability, transporter expression and efflux mechanisms.

n  Therapeutic evaluation

Monitor molecular and functional recovery following therapeutic intervention.

01 | BBB Model

Establish a relevant and reproducible BBB research model

Select the appropriate BBB model to address specific biological questions, from endothelial barrier biology to neurovascular unit function and disease-associated BBB dysfunction.

Representation of spheroid and organoid three-dimensional (3D) in vitro models of the blood-brain barrier (BBB) (PMID: 41126959).

Model systems

Endothelial models
Brain microvascular endothelial cells | Primary brain endothelial cells

Co-culture models
Endothelial–pericyte | Endothelial–astrocyte | Multicellular neurovascular unit

Advanced models
Transwell BBB | BBB-on-a-chip | Microfluidic BBB

Disease models
Neuroinflammation | Neurodegeneration | Ischemia | Brain tumor | Other BBB dysfunction models

Representative Ready-to-Use BBB Model Platform

PharmaCo-Cell BBB Kit™

Multicellular BBB models designed for barrier function, permeability, drug transport, and disease-modeling research.

https://www.pharmacocell.co.jp/en/

Research focus

BBB development | Barrier integrity | Neurovascular unit | Disease modeling | Therapeutic evaluation

02 | Molecular Validation

Validate BBB Identity, Integrity and Function

A focused antibody portfolio for molecular characterization of the blood–brain barrier (BBB)—from endothelial identity and junctional organization to transporter expression and barrier function.

n  Endothelial Identity

Define BBB endothelial cell identity and characterize the vascular phenotype of in vitro and in vivo BBB models.

n  Junctional Integrity

Assess tight-junction organization, continuity and localization—key molecular features underlying BBB paracellular barrier function.

n  Transporter & Efflux

Characterize the selective transport and drug-efflux properties that distinguish the BBB from peripheral vascular barriers.

03 |  Neurovascular Unit Characterization

Define the cellular architecture and microenvironment of the BBB

BBB function is governed not only by brain endothelial cells, but by coordinated interactions within the neurovascular unit (NVU).
A comprehensive marker panel enables characterization of pericytes, astrocytes, microglia, neurons and vascular basement membrane, providing a multidimensional view of BBB structure, cellular crosstalk and pathological remodeling.

Multicellular BBB models provide a functional context for studying endothelial–pericyte–astrocyte interactions within the neurovascular unit. (https://www.pharmacocell.co.jp/en/)

Key NVU Components

Schematic of the NVU. (PMID: 36139398)

From Cellular Architecture to BBB Pathology

From cellular identity and neurovascular unit (NVU) organization to cell–cell/ECM interactions, BBB structural integrity, neurovascular function, and disease-associated remodeling, a multidimensional approach enables comprehensive characterization of BBB architecture, function, and pathological changes. We provide validated antibodies and integrated research solutions covering BBB cell identity, NVU organization, junctional integrity, cellular interactions, transport function, and disease-associated remodeling—supporting BBB research from cellular architecture and molecular mechanisms to functional validation.
 

Research Applications

·  BBB integrity & vascular remodeling

·  Pericyte loss and vascular instability

·  Astrocyte–endothelial interaction

·  Microglia-mediated neuroinflammation

·  Neurovascular coupling & neuronal–vascular communication

·  Basement membrane remodeling

·  Neurodegeneration-associated BBB dysfunction

·  Stroke, neuroinflammation and cerebrovascular disease

04 | BBB Dysfunction Research

From Barrier Disruption to Molecular Mechanisms

BBB dysfunction is a central feature of numerous neurological and cerebrovascular disorders.
Systematic profiling of inflammatory signaling, oxidative stress, hypoxia/angiogenesis, cellular injury, junctional disruption, and extracellular matrix remodeling enables researchers to dissect the molecular mechanisms underlying BBB breakdown and neurovascular dysfunction.

Mechanism of BBB disruption in the brain. ( PMID: 39860392)
 

Key Pathological Mechanisms

Mechanistic Research Framework

Pathological Stress → Molecular Signaling → NVU Injury → Junction/ECM Remodeling → BBB Breakdown → Disease Progression provides a mechanistic framework for understanding how pathological stimuli activate key pathways such as NF-κB, Nrf2, HIF-1α, and VEGF, drive endothelial and neurovascular unit injury, disrupt tight junctions and the extracellular matrix, and ultimately compromise BBB integrity and promote disease progression.

We provide validated antibodies and research solutions spanning BBB cell identity, barrier integrity, signaling pathways, cellular injury, and disease remodeling, enabling mechanistic investigation from molecular events to spatial and functional validation.

Disease-Relevant Research Areas

·  Neuroinflammation

·  Ischemic stroke & hypoxic injury

·  Neurodegenerative disease

·  Cerebrovascular disorders

·  Brain tumor progression

·  BBB-associated drug delivery

·  Vascular aging & endothelial dysfunction

Multiparametric BBB Characterization

Connect Structure, Function and Molecular Mechanisms

A multiparametric characterization strategy integrates BBB identity, barrier structure, transport activity, pathological signaling and neurovascular unit composition to provide a comprehensive assessment of BBB phenotype and function.

Integrated Research Dimensions

Key References

1. Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood–brain barrier: Structure, regulation and drug delivery. Signal Transduct Target Ther. 2023;8:217.

2. O'Halloran L, Akinsete O, Kogan AL, Wrona M, Mahdi AF. 3D in vitro blood-brain barrier models: recent advances and their role in brain disease research and therapy. Front Pharmacol. 2025;16:1637602.

3. Sato Y, Falcone-Juengert J, Tominaga T, Su H, Liu J. Remodeling of the Neurovascular Unit Following Cerebral Ischemia and Hemorrhage. Cells. 2022;11(18):2823.

4. Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584–1596.

5. Kim S, Jung UJ, Kim SR. The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications. J Clin Med. 2025;14(2):386.